The field of heart failure (HF) has seen remarkable advances in recent years. Despite
a growing armamentarium of medications changing the paradigm of care from triple to
quintuple therapy, HF continues to be associated with high health care costs, increasing
incidence, and frequent hospitalizations.
1
,2
The effects of COVID-19 on delivery of care to those with chronic health conditions
have further emphasized the need for mobile health (mHealth) technologies for patients
with HF.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis.CMAJ Open. 2016; 4: E365
- The need for heart failure advocacy in Canada.Can J Cardiol. 2017; 33: 1450-1454
- The next wave of health care strain related to COVID-19: heart failure patients coming back in force-we must not fail them.Can J Cardiol. 2020; 36: 993-994
- 2021 ISHNE/HRS/EHRA/APHRS expert collaborative statement on mHealth in arrhythmia management: digital medical tools for heart rhythm professionals: from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.Circ Arrhythm Electrophysiol. 2021; 14e009204
- Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.Heart. 2021; 107: 366-372
- Telemonitoring in patients with heart failure.N Engl J Med. 2010; 363: 2301-2309
- Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the Better Effectiveness After Transition – Heart Failure (BEAT-HF) randomized clinical trial.JAMA Intern Med. 2016; 176: 310-318
- Home monitoring with technology-supported management in chronic heart failure: a randomised trial.Heart. 2020; 106: 1573-1578
- Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.Lancet. 2018; 392: 1047-1057
- Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.Lancet. 2011; 377: 658-666
- Effectiveness of mobile health technology interventions for patients with heart failure: systematic review and meta-analysis.Can J Cardiol. 2021; 37: 1248-1259
Article info
Publication history
Published online: March 25, 2021
Accepted:
March 4,
2021
Received:
February 24,
2021
Footnotes
See article by Kitsiou et al., pages 1248–1259 of this issue.
See page 1164 for disclosure information.
Identification
Copyright
© 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Effectiveness of Mobile Health Technology Interventions for Patients With Heart Failure: Systematic Review and Meta-analysisCanadian Journal of CardiologyVol. 37Issue 8
